Results 51 to 60 of about 205 (134)
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study. [PDF]
Intest ResTursi A, Mocci G, Costa F, Ceccarelli L, Savarino E, De Barba C, Mucherino C, D'Antonio E, Montesano L, Marzo M, Scaldaferri F, Napolitano D, Pugliese D, Gravina AG, Pellegrino R, Spagnuolo R, Luzza F, Cuomo A, Donnarumma L, Maconi G, Cataletti G, Bertani L, Bodini G, Pasta A, Piergallini S, Serio M, Scarcelli A, Capone P, Cortellini F, Rodino S, Sebkova L, Vespere G, Sedda S, D'Onofrio V, De Luca L, Gaiani F, Kayali S, Pagnini C, Graziani MG, Di Paolo MC, Allegretta L, Cazzato AI, Scorza S, Ferronato A, Ribaldone DG, Aragona G, Perazzo P, Forti G, Di Fonzo M, Iacopini F, Pica R, Cassieri C, Onidi FM, Usai Satta P, Elisei W, Picchio M, Papa A. +56 moreeuropepmc +1 more sourceIntra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use. [PDF]
Eur Heart J Imaging Methods PractMarfella R, Marfella LV, Fumagalli C, Rinaldi L, Sasso FC, Cozzolino D, Nappo F, Sellitto A, Romano C, Carusone C, Diodato G, Russo P, Marfella L, Tarantino NM, Carpinella G, Furbatto F, Gentile S, Guarino G, Satta E, Bellis A, Marinelli L, Donisi I, D'Onofrio N, Mauro C, Cappabianca S, Balestrieri ML, Sardu C. +26 moreeuropepmc +1 more sourceGLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study. [PDF]
Int J Mol SciSardu C, Marfella LV, Fumagalli C, Rinaldi L, Sasso FC, Cozzolino D, Nappo F, Sellitto A, Romano C, Carusone C, Russo P, Marfella L, Tarantino NM, Carpinella G, Furbatto F, Gentile S, Guarino G, Satta E, Bellis A, Marinelli L, Donisi I, D'Onofrio N, Mauro C, Cappabianca S, Balestrieri ML, Marfella R. +25 moreeuropepmc +1 more sourceUpadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study. [PDF]
J Clin MedMocci G, Tursi A, Scaldaferri F, Napolitano D, Pugliese D, Maconi G, Cataletti G, Pica R, Cassieri C, Savarino EV, De Barba C, Costa F, Ceccarelli L, Marzo M, Elisei W, Monterubbianesi R, Faggiani R, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodinò S, Sebkova L, Bodini G, Pasta A, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Gravina AG, Pellegrino R, Vespere G, Sedda S, D'Onofrio V, De Luca L, Allegretta L, Cazzato AI, Fanigliuolo L, Grossi L, Cortellini F, Forti G, Tonti P, Neve V, Piergallini S, Di Fonzo M, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'Antonio E, Montesano L, Cocco A, D'Ascoli B, Colucci R, Bachetti F, Orrù G, Onidi FM, Usai Satta P, Picchio M, Papa A. +63 moreeuropepmc +1 more sourceClinical and Genetic Characteristics of Pediatric Patients with Inflammatory Bowel Disease Transitioning to Adult Medicine: A Single-Center Ten-Year Experience. [PDF]
J Clin MedMocci G, Orrù G, Onidi FM, Corpino M, Marongiu A, Argiolas GM, Runfola M, Manunza R, Locci G, Tamponi E, Zolfino T, Usai Satta P, Muscas A, Rossino R, Savasta S, Congia M. +15 moreeuropepmc +1 more sourceLong-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study. [PDF]
J Clin MedMocci G, Tursi A, Scaldaferri F, Napolitano D, Pugliese D, Capobianco I, Bartocci B, Bartocci B, Blasi V, Savarino EV, Maniero D, Redavid C, Lorenzon G, Cuomo A, Donnarumma L, Gravina AG, Pellegrino R, Bodini G, Pasta A, Marzo M, Serio M, Scarcelli A, Rodinò S, Sebkova L, Maconi G, Cataletti G, Luppino I, Checchin D, Ferronato A, Gaiani F, Kayali S, Felice C, Pranzo G, Catarella D, D'Agostino D, Di Bartolo E, Lombardi G, Patturelli M, Bendia E, Bolognini L, Balducci D, Quatraccioni C, Martini F, Mucherino C, D'Antonio E, Montesano L, Vespere G, Sedda S, D'Onofrio V, De Luca L, Spagnuolo R, Luzza F, Fanigliulo L, Rocco G, Sacchi C, Zampaletta C, Grossi L, Lorenzetti R, Aragona G, Perazzo P, Forti G, Allegretta L, Cazzato AI, Scorza S, Cortellini F, Capone P, Villani GD, Di Fonzo M, Iacopini F, Tonti P, Neve V, Colucci R, Elisei W, Monterubbianesi R, Faggiani R, Pica R, Pagnini C, Graziani MG, Di Paolo MC, Onidi FM, Saba F, Dore MP, Usai-Satta P, Picchio M, Papa A. +84 moreeuropepmc +1 more sourceAn inverse probability of treatment weighted comparison between vedolizumab, ustekinumab, and tofacitinib in anti-TNF-experienced ulcerative colitis patients. [PDF]
Ther Adv GastroenterolTursi A, Pasta A, Elisei W, Barberio B, Bertin L, Mocci G, Maconi G, Gravina AG, Pellegrino R, Bodini G, Papa A, Savarino EV, Italian Network for Inflammatory Bowel Diseases (IN-IBD). +12 moreeuropepmc +1 more sourceGermline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study. [PDF]
BMC Cancer, 2019 Casula M, Paliogiannis P, Ayala F, De Giorgi V, Stanganelli I, Mandalà M, Colombino M, Manca A, Sini MC, Caracò C, Ascierto PA, Satta RR, Melanoma Unit of Sassari (MUS), Lissia A, Cossu A, Palmieri G, Italian Melanoma Intergroup (IMI). +16 moreeuropepmc +1 more sourceA narrative review on the environmental impact of medicines: from water analysis and <i>in vivo</i> studies to prescribing appropriateness, based on European and Italian legal frameworks. [PDF]
Front Drug Saf RegulCristini I, Poluzzi E, Soardo F, Crisafulli S, Polesello S, Kirchmayer U, Milani M, Russo F, Nicoletti M, Scroccaro G, Deambrosis P, Tavakolian Haghighi S, Grisotto J, Moretti U, Paolone G, Trifirò G. +15 moreeuropepmc +1 more source
